在慢性阻塞性肺病中,MG53缺陷介导的骨肌功能障碍通过损害线粒体裂变来影响慢性阻塞性肺病
Liwei Liao1, Ziwen Zheng1, Mingming Deng1
1National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
在慢性阻塞性肺病 (COPD) 患者中,Mitsugumin 53 缺乏会使缩症恶化. 恢复Mitsugumin 53水平可以对抗肌肉缩和线粒体功能障碍,为COPD相关的肌肉损耗提供潜在的治疗策略.
科学领域:
- 肌肉生理学 肌肉生理学
- 线粒体生物学 线粒体生物学
- 肺部医学 肺部医学
背景情况:
- 慢性阻塞性肺病 (COPD) 中的沙科佩尼亚与肌动素失调和线粒体功能障碍有关.
- 了解特定的肌和线粒体通路的作用对于开发有效的COPD治疗非常重要.
研究的目的:
- 为了研究肌基因,特别是53,在与COPD相关的肉症中的作用.
- 探索三素53,线粒体功能障碍和COPD肌肉衰竭之间的联系.
主要方法:
- 与酶相关的免疫吸收试验 (ELISA) 用于测量COPD患者的血密苏古53水平.
- 使用Mitsugumin 53-Knockout小鼠和 in vitro/in vivo 模型来研究卷烟引起的肌肉功能障碍.
- 采用多omics测序,活细胞成像和分子实验来阐明机制.
主要成果:
- 在COPD患者中,较低的血Mitsugumin 53水平与骨肌肉功能障碍相关.
- 三素53缺乏症加剧了吸烟引起的肌肉缩和调节的线粒体裂变.
- 再组合密苏古53补充剂缓解了肌肉缩并挽救了线粒体功能障碍.
结论:
- 三古53是COPD中萨尔科佩尼亚的关键调节剂.
- 三重53和线粒体裂变为COPD肌肉功能障碍的潜在治疗标.
更多相关视频
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
Published on: November 23, 2011
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
相关概念视频
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Cystic Fibrosis: Management
Sinus disease and chronic...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Mitochondria
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
